Published in J Ocul Biol Dis Infor on December 12, 2009
DNA repair mechanisms and Toxoplasma gondii infection. Arch Microbiol (2013) 0.75
Bioinformatics and the eye. J Ocul Biol Dis Infor (2010) 0.75
Toxoplasmosis. Lancet (2004) 13.96
Toxoplasma gondii: from animals to humans. Int J Parasitol (2000) 10.45
Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem (2007) 7.49
Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis (1995) 6.79
Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature (1992) 4.92
TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science (2005) 4.86
Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol (1991) 4.69
Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue. Nature (2006) 4.50
Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med (2008) 4.46
Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE (2007) 4.46
A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science (2006) 4.44
Viruses and apoptosis. Annu Rev Microbiol (1999) 4.24
Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science (2006) 4.23
Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol (2001) 4.12
Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J Biol Chem (2005) 3.87
Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol (2006) 3.43
Transient transfection and expression in the obligate intracellular parasite Toxoplasma gondii. Science (1993) 3.36
Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science (2001) 3.21
Specific DNA-binding by apicomplexan AP2 transcription factors. Proc Natl Acad Sci U S A (2008) 3.10
Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. Proc Natl Acad Sci U S A (1993) 3.01
Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J Parasitol (1992) 2.98
Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med (1996) 2.97
Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space. Cell (2006) 2.79
Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis. J Exp Med (2005) 2.76
Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood (2003) 2.65
Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. Ann Intern Med (1992) 2.57
CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood (2005) 2.22
Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Infect Immun (2005) 2.21
Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr Opin Microbiol (2002) 2.21
Safe haven: the cell biology of nonfusogenic pathogen vacuoles. Annu Rev Microbiol (1997) 2.07
Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol (2006) 2.07
The transcriptome of Toxoplasma gondii. BMC Biol (2005) 2.06
Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. J Biol Chem (2001) 2.06
Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis (2006) 2.00
Toxoplasma gondii targets a protein phosphatase 2C to the nuclei of infected host cells. Eukaryot Cell (2006) 1.97
Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J Cell Biol (2000) 1.96
Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J Immunol (2007) 1.95
Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med (Berl) (2007) 1.90
Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology (1999) 1.86
The development and biology of bradyzoites of Toxoplasma gondii. Front Biosci (2000) 1.84
Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression. Eukaryot Cell (2002) 1.81
Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J Biol Chem (2001) 1.78
Cloning and characterization of a bradyzoite-specifically expressed gene (hsp30/bag1) of Toxoplasma gondii, related to genes encoding small heat-shock proteins of plants. Mol Microbiol (1995) 1.75
Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. Drug Discov Today (2005) 1.74
CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J Immunol (2001) 1.73
Histone-modifying complexes regulate gene expression pertinent to the differentiation of the protozoan parasite Toxoplasma gondii. Mol Cell Biol (2005) 1.72
Epigenomic modifications predict active promoters and gene structure in Toxoplasma gondii. PLoS Pathog (2007) 1.69
Genetic analysis of tachyzoite to bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene induction. Mol Microbiol (2002) 1.61
Staying alive: bacterial inhibition of apoptosis during infection. Trends Microbiol (2008) 1.61
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol (2003) 1.57
Expressed sequence tag analysis of the bradyzoite stage of Toxoplasma gondii: identification of developmentally regulated genes. Infect Immun (1998) 1.55
Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol (1998) 1.53
Dissemination of Toxoplasma gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminescence imaging. Cell Microbiol (2005) 1.53
Activation of NF-kappaB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane. J Cell Sci (2003) 1.52
The transcription of bradyzoite genes in Toxoplasma gondii is controlled by autonomous promoter elements. Mol Microbiol (2008) 1.50
The host cell transcription factor hypoxia-inducible factor 1 is required for Toxoplasma gondii growth and survival at physiological oxygen levels. Cell Microbiol (2006) 1.50
Iron and pH homeostasis intersect at the level of Fur regulation in the gastric pathogen Helicobacter pylori. Infect Immun (2006) 1.48
TLR adaptor MyD88 is essential for pathogen control during oral toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite. J Immunol (2008) 1.47
Toxoplasma gondii dysregulates IFN-gamma-inducible gene expression in human fibroblasts: insights from a genome-wide transcriptional profiling. J Immunol (2007) 1.44
Forward genetic analysis of the apicomplexan cell division cycle in Toxoplasma gondii. PLoS Pathog (2008) 1.38
Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence. APMIS (2009) 1.36
The proteome of Toxoplasma gondii: integration with the genome provides novel insights into gene expression and annotation. Genome Biol (2008) 1.35
A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol (2001) 1.32
Unique gene expression profiles of donor-matched human retinal and choroidal vascular endothelial cells. Invest Ophthalmol Vis Sci (2007) 1.32
Inhibition of caspase activation and a requirement for NF-kappaB function in the Toxoplasma gondii-mediated blockade of host apoptosis. J Cell Sci (2003) 1.30
Toxoplasma gondii down-regulates MHC class II gene expression and antigen presentation by murine macrophages via interference with nuclear translocation of STAT1alpha. Eur J Immunol (2001) 1.30
Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-gamma signaling. J Immunol (2006) 1.27
Toxoplasma gondii: purine synthesis and salvage in mutant host cells and parasites. Exp Parasitol (1982) 1.27
Host-pathogen interactions: a diversity of themes, a variety of molecular machines. Curr Opin Microbiol (2005) 1.26
Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy. Proc Natl Acad Sci U S A (1994) 1.26
Discovery of parasite virulence genes reveals a unique regulator of chromosome condensation 1 ortholog critical for efficient nuclear trafficking. Proc Natl Acad Sci U S A (2007) 1.21
Identification and characterization of differentiation mutants in the protozoan parasite Toxoplasma gondii. Mol Microbiol (2002) 1.20
Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development. PLoS Pathog (2006) 1.19
Cytokine regulation of immunopathology in toxoplasmosis. Immunol Cell Biol (2007) 1.19
Chemokine secretion of human cells in response to Toxoplasma gondii infection. Infect Immun (1999) 1.18
Modulation of the host cell proteome by the intracellular apicomplexan parasite Toxoplasma gondii. Infect Immun (2007) 1.18
Host and parasite-derived IKK activities direct distinct temporal phases of NF-kappaB activation and target gene expression following Toxoplasma gondii infection. J Cell Sci (2005) 1.17
The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis. J Infect Dis (2002) 1.16
The antioxidant systems in Toxoplasma gondii and the role of cytosolic catalase in defence against oxidative injury. Mol Microbiol (2004) 1.15
A patatin-like protein protects Toxoplasma gondii from degradation in activated macrophages. Mol Microbiol (2006) 1.12
Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp Parasitol (1999) 1.12
Localized recrudescence of Toxoplasma infections in the central nervous system of immunocompromised mice assessed by in vivo bioluminescence imaging. Microbes Infect (2007) 1.12
Pair of unusual GCN5 histone acetyltransferases and ADA2 homologues in the protozoan parasite Toxoplasma gondii. Eukaryot Cell (2006) 1.11
A bradyzoite stage-specifically expressed gene of Toxoplasma gondii encodes a polypeptide homologous to lactate dehydrogenase. Mol Biochem Parasitol (1995) 1.11
The induction of acute ileitis by a single microbial antigen of Toxoplasma gondii. J Immunol (2004) 1.10
Mechanisms underlying the manipulation of host apoptotic pathways by Toxoplasma gondii. Int J Parasitol (2004) 1.10
Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation. Cell Microbiol (2007) 1.09
Drug inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites. J Exp Med (2009) 1.08
MYST family histone acetyltransferases in the protozoan parasite Toxoplasma gondii. Eukaryot Cell (2005) 1.07
Toxoplasma gondii rhoptry discharge correlates with activation of the early growth response 2 host cell transcription factor. Infect Immun (2008) 1.04
Initiation and termination of NF-kappaB signaling by the intracellular protozoan parasite Toxoplasma gondii. J Cell Sci (2005) 1.04
Overcoating of Toxoplasma parasitophorous vacuoles with host cell vimentin type intermediate filaments. J Eukaryot Microbiol (1994) 1.03
Epidemiology of toxoplasmosis among pregnant women in the Paris area. Int J Epidemiol (1988) 1.03
Molecular cloning of the Toxoplasma gondii sag4 gene encoding an 18 kDa bradyzoite specific surface protein. Mol Biochem Parasitol (1996) 1.03
Transcriptional profile of Toxoplasma gondii-infected human fibroblasts as revealed by gene-array hybridization. Mol Genet Genomics (2001) 1.02
Primary skeletal muscle cells trigger spontaneous Toxoplasma gondii tachyzoite-to-bradyzoite conversion at higher rates than fibroblasts. Int J Med Microbiol (2008) 1.02
Diverse mechanisms employed by Toxoplasma gondii to inhibit IFN-gamma-induced major histocompatibility complex class II gene expression. Microbes Infect (2006) 1.01
Nuclear factor-kappa B plays a major role in the regulation of chemokine expression of HeLa cells in response to Toxoplasma gondii infection. Parasitol Res (2001) 1.00
Toll-like receptor 4 mediates tolerance in macrophages stimulated with Toxoplasma gondii-derived heat shock protein 70. Infect Immun (2005) 0.99
Ocular toxoplasmosis: in the storm of the eye. Parasite Immunol (2006) 0.99
Toxoplasma gondii asexual development: identification of developmentally regulated genes and distinct patterns of gene expression. Eukaryot Cell (2002) 1.81
Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription. J Biol Chem (2001) 1.78
The host cell transcription factor hypoxia-inducible factor 1 is required for Toxoplasma gondii growth and survival at physiological oxygen levels. Cell Microbiol (2006) 1.50
Toxoplasma gondii rhoptry discharge correlates with activation of the early growth response 2 host cell transcription factor. Infect Immun (2008) 1.04
Toxoplasma gondii activates hypoxia-inducible factor (HIF) by stabilizing the HIF-1alpha subunit via type I activin-like receptor kinase receptor signaling. J Biol Chem (2010) 0.98
Peculiarities of host cholesterol transport to the unique intracellular vacuole containing Toxoplasma. Traffic (2005) 0.95
Detection of cytoplasmic glycosylation associated with hydroxyproline. Methods Enzymol (2006) 0.92
The Skp1 protein from Toxoplasma is modified by a cytoplasmic prolyl 4-hydroxylase associated with oxygen sensing in the social amoeba Dictyostelium. J Biol Chem (2012) 0.92
Whole genome profiling of spontaneous and chemically induced mutations in Toxoplasma gondii. BMC Genomics (2014) 0.89
Host cell invasion by Toxoplasma gondii is temporally regulated by the host microtubule cytoskeleton. Eukaryot Cell (2010) 0.88
Serum response factor regulates immediate early host gene expression in Toxoplasma gondii-infected host cells. PLoS One (2011) 0.88
CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect Immun (2010) 0.86
Dependence of stress resistance on a spore coat heteropolysaccharide in Dictyostelium. Eukaryot Cell (2008) 0.83
The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice. Infect Immun (2007) 0.81
Regulation of immunopathogenesis during Plasmodium and Toxoplasma infections: more parallels than distinctions? Trends Parasitol (2013) 0.80